TILT Sets Fourth Quarter and Full Year 2022 Conference Call for March 16 at 5:00 p.m. ET
27 févr. 2023 07h30 HE
|
TILT Holdings Inc.
PHOENIX, Feb. 27, 2023 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT" or the “Company”) (NEO:TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation...
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
24 févr. 2023 16h20 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Feb. 24, 2023 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted...
Studio City Announces Earnings Release Date
24 févr. 2023 08h39 HE
|
Studio City
MACAU, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC), a world-class integrated resort located in Cotai, Macau, today announces that it will release its...
Broadwind Reports Fourth Quarter and Full-Year 2022 Conference Call and Webcast Date
23 févr. 2023 18h00 HE
|
Broadwind
CICERO, Ill., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Broadwind (NASDAQ: BWEN), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced that it...
Visteon Announces 2022 Financial Results and 2023 Outlook
16 févr. 2023 06h55 HE
|
Visteon Corporation
VAN BUREN TOWNSHIP, Mich., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Visteon Corporation (NASDAQ: VC) today reported fourth quarter and full-year 2022 financial results that exceed its previous outlook....
Visteon to Announce Fourth Quarter and Full-Year 2022 Results on Feb. 16
27 janv. 2023 11h00 HE
|
Visteon Corporation
VAN BUREN TOWNSHIP, Mich., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry, will release its fourth quarter 2022 and...
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
22 déc. 2022 16h00 HE
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...
Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
16 nov. 2022 00h00 HE
|
Alvotech
Revenue for first nine months of 2022 increased to $59.2 million, compared to $2.0 million for the same period in 2021 Discussions with U.S. FDA progressed regarding both biologic license...
Alvotech kynnir uppgjör fyrir fyrstu níu mánuði ársins 2022 og skýrir frá helstu áföngum í rekstri
15 nov. 2022 23h55 HE
|
Alvotech
Tekjur fyrstu níu mánuði ársins voru 8,7 milljarðar króna samanborið við 291 milljón króna á sama tímabili í fyrraViðræður héldu áfram við Bandaríska lyfjaeftirlitið (FDA) um meðferð beggja umsókna um...
Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
15 nov. 2022 23h55 HE
|
Alvotech
Revenue for first nine months of 2022 increased to $59.2 million, compared to $2.0 million for the same period in 2021Discussions with U.S. FDA progressed regarding both biologic license applications...